PATENT CLAIM ANALYSIS

Application Number: 16325626
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["514", "256000"]

Abstract:
Provided are a phosphodiesterase-4 (PDE4) inhibitor and application thereof in preparation of a medication for treating a disease related to PDE4. Specifically disclosed is a compound as shown in formula (I) and a pharmaceutically acceptable salt thereof.

Claim (Index 24):
A method for treating a disease related to PDE4 in a subject in need thereof, comprising administering an effective amount of the pharmaceutical composition according to  claim 22  to the subject.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 99.0
- Lexical Diversity: 1.34375
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16326976', '15314599', '16317510', '15128064', '15812142']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7712863836705451
- 35 USC 102 Novelty (BERT): 0.5463157846615033
- Combined Prediction Score: 0.7487893237696409
- Mean Citation Score: 379.939528
- Max Citation Score: 390.95236
- Similarity Product: 308.3369430983972

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test